Skip to main content
Roche launches companion Dx for breast, gastric cancer drug

Roche Holding is launching the VENTANA HER2 Dual ISH DNA Probe Cocktail assay, a companion diagnostic test designed to identify HER2-positive breast or gastric cancer patients who can benefit from Herceptin therapy, in Europe, Africa, Asia Pacific, Middle East and Latin America. The company said it will seek approval for use in the US from the FDA.

Full Story: